NextGen Bioscience this week announced it has formed a scientific advisory board. The three-person board consists of Anders Beogh Jensen, Wang Chong, and John Savin.
Jensen is director at Poalis, and an industrial representative board member of the Danish Society for Biochemistry and Molecular Biology.
Chong is a physician whose experience includes being CFO and commercial director of Phytopharm, CEO of Osmetech, and life sciences analyst at Canaccord Capital.
Savin has served as CEO of Physiomics and an analyst at Gerrard Group, an investment bank.
Can “Jon” Ozbal has been promoted by BioTrove to vice president and general manager of the company’s RapidFire division. Ozbal is a member of the “original BioTrove team,” the company said in a statement, and is responsible for much of the RapidFire lead discovery development. RapidFire Mass Spectrometry uses microfluidic technology to facilitate analysis at faster than 10 seconds per sample.
Before joining BioTrove, Ozbal was an instructor at the Massachusetts Institute of Technology.
The company also said that Kevin Munnelly was promoted to vice president and general manager of its OpenArray division.